A phase II trial of stereotactic body radiotherapy in 4 fractions for patients with localized prostate cancer

Overview of attention for article published in Radiation Oncology, April 2022

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (70th percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

So far, Altmetric has seen 7 X posts from 7 X users, with an upper bound of 13,030 followers.

A phase II trial of stereotactic body radiotherapy 36 Gy in 4 fractions for patients with localised #prostatecancer https://t.co/gaYlzA2qv4

RT @radiotherapy_uk: A phase II trial of stereotactic body radiotherapy 36 Gy in 4 fractions for patients with localized #prostatecancer…

RT @radiotherapy_uk: A phase II trial of stereotactic body radiotherapy 36 Gy in 4 fractions for patients with localized #prostatecancer…

RT @radiotherapy_uk: A phase II trial of stereotactic body radiotherapy 36 Gy in 4 fractions for patients with localized #prostatecancer…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 3 additional X posts.